In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction

Arjun Jayaraj1, Robert Fuller1, Seshadri Raju1

  • 1The RANE Center for Venous & Lymphatic Diseases, St. Dominic Hospital, Jackson, Miss.

Insights

In-stent restenosis (ISR) and stent compression (SC) are common after chronic iliofemoral venous stenting but not always progressive. Reintervention is indicated by symptoms, not just measurements, with good outcomes expected.

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Cardiovascular Research

Background:

  • In-stent restenosis (ISR) and stent compression (SC) are frequent complications following stenting for chronic iliofemoral venous obstruction.
  • These complications are primary drivers for reintervention, yet their detailed characteristics and outcomes post-reintervention remain underexplored.

Purpose of the Study:

  • To investigate the characteristics of ISR and SC after iliofemoral venous stenting.
  • To analyze risk factors associated with the development of ISR and SC.
  • To evaluate clinical outcomes and stent patency following reintervention for ISR and SC.

Main Methods:

  • Retrospective analysis of 578 limbs/patients undergoing unilateral iliofemoral venous stenting (2014-2018).
  • ISR and SC prevalence, onset, and progression assessed using duplex ultrasound and intravascular ultrasound.
  • Risk factor analysis and reintervention outcomes, including patency rates and clinical improvement, were evaluated.

Main Results:

  • ISR prevalence reached 74% by 3 months, while SC was noted in 80% on day 1, with both stabilizing thereafter.
  • Significant risk factors for ISR included stent inflow luminal area and shear rate; asymmetric stent sizing was a risk factor for SC.
  • 16.4% of limbs required reintervention, with significant improvements in swelling and pain scores post-reintervention. 60-month patency rates were high (70-98%).

Conclusions:

  • ISR and SC are common but not relentlessly progressive after iliofemoral venous stenting.
  • Reintervention decisions should prioritize symptomatic improvement and quality of life over arbitrary ISR/SC thresholds.
  • Reintervention yields favorable clinical outcomes and long-term stent patency; further research into shear rate's role in ISR is warranted.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
85
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
74
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
89
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
63
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
58
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
85